DEVLIN JODI (President, Therapeutics) sold 8.3% of their position (4.76K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market sale worth $24.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/21/2025ACC: 0001826667-25-000059
Officer· President, Therapeutics
Since Aug 2023
+19.37K
Net shares
Net buyer
$24.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
24.13K acquired · 4.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.13K
Price / share
$5.18
Trade value
$125K
% of position
72.3%
5/19/2025
33.40K→57.53K
Common Stock
Direct
Shares
−4.76K
Price / share
$5.18
Trade value
$24.68K
% of position
8.3%
5/19/2025
57.53K→52.76K
Total
Net shares
+19.37K
Net value
$100.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2025 | A · Award | +24.13K | $5.18 | $125K | 72.3% | 33.40K | 57.53K |
| Common Stock Direct | 5/19/2025 | S · Sale | −4.76K | $5.18 | $24.68K | 8.3% | 57.53K | 52.76K |
| Total | +19.37K | $100.32K | ||||||
Derivative Transactions0
No derivative transactions reported